{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:19:56Z","timestamp":1793621996872,"version":"4.5.0"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170910"],"award-info":[{"award-number":["32170910"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20250130"],"award-info":[{"award-number":["BK20250130"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jinshan Talents of High-level Talents Project in Medical Field","award":["No. JSYC2024-002"],"award-info":[{"award-number":["No. JSYC2024-002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02998-7","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:05:19Z","timestamp":1781528719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neurotransmitters in cancer: how receptor signaling and posttranslational modifications modulate tumor progression and offer new therapeutic targets"],"prefix":"10.1186","volume":"24","author":[{"given":"Xuanyin","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hele","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"2998_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41388-019-1006-0","volume":"39","author":"SH Jiang","year":"2020","unstructured":"Jiang SH, Hu LP, Wang X, Li J, Zhang ZG. Neurotransmitters: emerging targets in cancer. Oncogene. 2020;39:503\u201315.","journal-title":"Oncogene"},{"key":"2998_CR2","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3389\/fimmu.2020.01869","volume":"11","author":"TW Hodo","year":"2020","unstructured":"Hodo TW, de Aquino MTP, Shimamoto A, Shanker A. Critical neurotransmitters in the neuroimmune network. Front Immunol. 2020;11:1869.","journal-title":"Front Immunol"},{"key":"2998_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10072-022-06413-0","volume":"44","author":"M Oshaghi","year":"2023","unstructured":"Oshaghi M, Kourosh-Arami M, Roozbehkia M. Role of neurotransmitters in immune-mediated inflammatory disorders: a crosstalk between the nervous and immune systems. Neurol Sci. 2023;44:99\u2013113.","journal-title":"Neurol Sci"},{"key":"2998_CR4","doi-asserted-by":"publisher","first-page":"1229397","DOI":"10.3389\/fimmu.2023.1229397","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Zhang R, Hei H. Advances in post-translational modifications of proteins and cancer immunotherapy. Front Immunol. 2023;14:1229397.","journal-title":"Front Immunol"},{"key":"2998_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00213-010-1984-7","volume":"213","author":"Y Dai","year":"2011","unstructured":"Dai Y, Dudek NL, Li Q, Muma NA, Phospholipase C. Ca2+, and calmodulin signaling are required for 5-HT2A receptor-mediated transamidation of Rac1 by transglutaminase. Psychopharmacology. 2011;213:403\u201312.","journal-title":"Psychopharmacology"},{"key":"2998_CR6","doi-asserted-by":"publisher","first-page":"e1000229","DOI":"10.1371\/journal.pbio.1000229","volume":"7","author":"N Paulmann","year":"2009","unstructured":"Paulmann N, Grohmann M, Voigt JP, Bert B, Vowinckel J, Bader M, Skelin M, Jevsek M, Fink H, Rupnik M, Walther DJ. Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol. 2009;7:e1000229.","journal-title":"PLoS Biol"},{"key":"2998_CR7","doi-asserted-by":"publisher","first-page":"218396","DOI":"10.1016\/j.canlet.2026.218396","volume":"645","author":"T Ling","year":"2026","unstructured":"Ling T, Zhang W, Cai H, Kien TT, Yan T, Wang J, Chen J. TGM2-mediated serotonylation in tumor endothelial cells promotes angiogenesis and tumor growth in colorectal cancer. Cancer Lett. 2026;645:218396.","journal-title":"Cancer Lett"},{"key":"2998_CR8","doi-asserted-by":"publisher","first-page":"183544","DOI":"10.1172\/JCI183544","volume":"135","author":"K Liu","year":"2025","unstructured":"Liu K, Zhang Y, Du G, Chen X, Xiao L, Jiang L, Jing N, Xu P, Zhao C, Liu Y, et al. 5-HT orchestrates histone serotonylation and citrullination to drive neutrophil extracellular traps and liver metastasis. J Clin Invest. 2025;135:183544.","journal-title":"J Clin Invest"},{"key":"2998_CR9","doi-asserted-by":"crossref","unstructured":"Zhang N, Wu J, Hossain F, Peng H, Li H, Gibson C, Chen M, Zhang H, Gao S, Zheng X, Wang Y, Zhu J, Wang JJ, Maze I, Zheng Q. Bioorthogonal labeling and enrichment of histone monoaminylation reveal its accumulation and regulatory function in cancer cell chromatin. J Am Chem Soc. 2024;7:10.1021.","DOI":"10.1101\/2024.03.20.586010"},{"key":"2998_CR10","doi-asserted-by":"publisher","first-page":"102302","DOI":"10.1016\/j.cbpa.2023.102302","volume":"74","author":"A Al-Kachak","year":"2023","unstructured":"Al-Kachak A, Maze I. Post-translational modifications of histone proteins by monoamine neurotransmitters. Curr Opin Chem Biol. 2023;74:102302.","journal-title":"Curr Opin Chem Biol"},{"key":"2998_CR11","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1021\/acs.jproteome.4c00379","volume":"23","author":"N Zhang","year":"2024","unstructured":"Zhang N, Gao S, Peng H, Wu J, Li H, Gibson C, Wu S, Zhu J, Zheng Q. Chemical proteomic profiling of protein dopaminylation in colorectal cancer cells. J Proteome Res. 2024;23:2651\u201360.","journal-title":"J Proteome Res"},{"key":"2998_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.molcel.2023.12.015","volume":"84","author":"X Wang","year":"2024","unstructured":"Wang X, Fu SQ, Yuan X, Yu F, Ji Q, Tang HW, Li RK, Huang S, Huang PQ, Qin WT, et al. A GAPDH serotonylation system couples CD8+ T cell glycolytic metabolism to antitumor immunity. Mol Cell. 2024;84:760\u2013e775767.","journal-title":"Mol Cell"},{"key":"2998_CR13","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.3748\/wjg.14.7175","volume":"14","author":"Y Liu","year":"2008","unstructured":"Liu Y, Li YH, Guo FJ, Wang JJ, Sun RL, Hu JY, Li GC. Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor alpha 3 subunit. World J Gastroenterol. 2008;14:7175\u201382.","journal-title":"World J Gastroenterol"},{"key":"2998_CR14","doi-asserted-by":"publisher","first-page":"102614","DOI":"10.1016\/j.ctrv.2023.102614","volume":"120","author":"M Borgeaud","year":"2023","unstructured":"Borgeaud M, Sandoval J, Obeid M, Banna G, Michielin O, Addeo A, Friedlaender A. Novel targets for immune-checkpoint inhibition in cancer. Cancer Treat Rev. 2023;120:102614.","journal-title":"Cancer Treat Rev"},{"key":"2998_CR15","doi-asserted-by":"publisher","first-page":"1264327","DOI":"10.3389\/fimmu.2023.1264327","volume":"14","author":"D Roy","year":"2023","unstructured":"Roy D, Gilmour C, Patnaik S, Wang LL. Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors. Front Immunol. 2023;14:1264327.","journal-title":"Front Immunol"},{"key":"2998_CR16","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.3390\/ph16101384","volume":"16","author":"D Liu","year":"2023","unstructured":"Liu D, Che X, Wang X, Ma C, Wu G. Tumor vaccines: unleashing the power of the immune system to fight cancer. Pharmaceuticals (Basel). 2023;16:1384.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2998_CR17","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1111\/j.1742-4658.2011.08347.x","volume":"278","author":"DJ Walther","year":"2011","unstructured":"Walther DJ, Stahlberg S, Vowinckel J. Novel roles for biogenic monoamines: from monoamines in transglutaminase-mediated post-translational protein modification to monoaminylation deregulation diseases. FEBS J. 2011;278:4740\u201355.","journal-title":"FEBS J"},{"key":"2998_CR18","first-page":"e67595","volume":"16","author":"PS Vellapandian","year":"2024","unstructured":"Vellapandian PS. Hypothalamic-Pituitary-Adrenal (HPA) axis: unveiling the potential mechanisms involved in stress-induced alzheimer\u2019s disease and depression. Cureus. 2024;16:e67595.","journal-title":"Cureus"},{"key":"2998_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ucl.2025.01.001","volume":"52","author":"A Al-Khanaty","year":"2025","unstructured":"Al-Khanaty A, Guduguntla AN, Lawrentschuk N, Bolton D, Eapen R. Adrenal anatomy and physiology. Urol Clin North Am. 2025;52:169\u201379.","journal-title":"Urol Clin North Am"},{"key":"2998_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s40364-025-00835-6","volume":"13","author":"W Chen","year":"2025","unstructured":"Chen W, Yu J, Ge S, Yuan T, Ding X, Yan B, Ye L, Wang Y, Jia R. Neurotransmitters in tumors: chemical cross-talk shaping tumor progression. Biomark Res. 2025;13:125.","journal-title":"Biomark Res"},{"key":"2998_CR21","doi-asserted-by":"publisher","first-page":"116609","DOI":"10.1016\/j.biopha.2024.116609","volume":"175","author":"H Zhang","year":"2024","unstructured":"Zhang H, Yang Y, Cao Y, Guan J. Effects of chronic stress on cancer development and the therapeutic prospects of adrenergic signaling regulation. Biomed Pharmacother. 2024;175:116609.","journal-title":"Biomed Pharmacother"},{"key":"2998_CR22","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.7150\/ijbs.79583","volume":"19","author":"Y Guan","year":"2023","unstructured":"Guan Y, Yao W, Yu H, Feng Y, Zhao Y, Zhan X, Wang Y. Chronic stress promotes colorectal cancer progression by enhancing glycolysis through beta2-AR\/CREB1 signal pathway. Int J Biol Sci. 2023;19:2006\u201319.","journal-title":"Int J Biol Sci"},{"key":"2998_CR23","doi-asserted-by":"publisher","first-page":"175718","DOI":"10.1016\/j.ejphar.2023.175718","volume":"949","author":"Y Lin","year":"2023","unstructured":"Lin Y, Liu Y, Gao Z, Jing D, Bi R, Cui X, Cao Q, Zhao Q, Gao R, Su Y, et al. Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancer. Eur J Pharmacol. 2023;949:175718.","journal-title":"Eur J Pharmacol"},{"key":"2998_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/HEP.0000000000000014","volume":"78","author":"S Fu","year":"2023","unstructured":"Fu S, Liu M, Zhu C, Zhang H, Zhao C, Xie Y, Chen G, Sheng D, Pan J, He Z, et al. Regulatory mucosa-associated invariant T cells controlled by beta1 adrenergic receptor signaling contribute to hepatocellular carcinoma progression. Hepatology. 2023;78:72\u201387.","journal-title":"Hepatology"},{"key":"2998_CR25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10735-022-10076-8","volume":"53","author":"C Gong","year":"2022","unstructured":"Gong C, Hu B, Chen H, Zhu J, Nie J, Hua L, Chen L, Fang Y, Hang C, Lu Y. beta2-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 signaling pathway. J Mol Histol. 2022;53:645\u201355.","journal-title":"J Mol Histol"},{"key":"2998_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2016.01.026","volume":"373","author":"C Wan","year":"2016","unstructured":"Wan C, Gong C, Zhang H, Hua L, Li X, Chen X, Chen Y, Ding X, He S, Cao W, et al. beta2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression. Cancer Lett. 2016;373:67\u201376.","journal-title":"Cancer Lett"},{"key":"2998_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1126\/science.aah5072","volume":"358","author":"AH Zahalka","year":"2017","unstructured":"Zahalka AH, Arnal-Estape A, Maryanovich M, Nakahara F, Cruz CD, Finley LWS, Frenette PS. Adrenergic nerves activate an angio-metabolic switch in prostate cancer. Science. 2017;358:321\u20136.","journal-title":"Science"},{"key":"2998_CR28","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1172\/JCI129502","volume":"129","author":"H Mohammadpour","year":"2019","unstructured":"Mohammadpour H, MacDonald CR, Qiao G, Chen M, Dong B, Hylander BL, McCarthy PL, Abrams SI, Repasky EA. beta2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J Clin Invest. 2019;129:5537\u201352.","journal-title":"J Clin Invest"},{"key":"2998_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nm1447","volume":"12","author":"PH Thaker","year":"2006","unstructured":"Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12:939\u201344.","journal-title":"Nat Med"},{"key":"2998_CR30","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41419-019-2030-2","volume":"10","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhang Y, He Z, Yin K, Li B, Zhang L, Xu Z. Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2. Cell Death Dis. 2019;10:788.","journal-title":"Cell Death Dis"},{"key":"2998_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3724\/abbs.2025216","volume":"58","author":"M Fan","year":"2026","unstructured":"Fan M, Zhao X. Role of the neurotransmitter-receptor pathway in T-cell tumor immunology and cancer immunotherapy. Acta Biochim Biophys Sin (Shanghai). 2026;58:67\u201389.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2998_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.brainres.2016.01.036","volume":"1641","author":"CA Mejias-Aponte","year":"2016","unstructured":"Mejias-Aponte CA. Specificity and impact of adrenergic projections to the midbrain dopamine system. Brain Res. 2016;1641:258\u201373.","journal-title":"Brain Res"},{"key":"2998_CR33","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.3389\/fimmu.2019.03082","volume":"10","author":"FL Baker","year":"2019","unstructured":"Baker FL, Bigley AB, Agha NH, Pedlar CR, O\u2019Connor DP, Bond RA, Bollard CM, Katsanis E, Simpson RJ. Systemic beta-adrenergic receptor activation augments the ex vivo expansion and anti-tumor activity of Vgamma9Vdelta2 T-Cells. Front Immunol. 2019;10:3082.","journal-title":"Front Immunol"},{"key":"2998_CR34","doi-asserted-by":"publisher","first-page":"1141712","DOI":"10.3389\/fimmu.2023.1141712","volume":"14","author":"A Singh","year":"2023","unstructured":"Singh A, Ranjan A. Adrenergic receptor signaling regulates the CD40-receptor mediated anti-tumor immunity. Front Immunol. 2023;14:1141712.","journal-title":"Front Immunol"},{"key":"2998_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12974-023-03005-3","volume":"21","author":"Y Hao","year":"2024","unstructured":"Hao Y, Su Y, He Y, Zhang W, Liu Y, Guo Y, Chen X, Liu C, Han S, Wang B, et al. Impaired cerebral microvascular endothelial cells integrity due to elevated dopamine in myasthenic model. J Neuroinflammation. 2024;21:10.","journal-title":"J Neuroinflammation"},{"key":"2998_CR36","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1158\/1078-0432.CCR-04-0059","volume":"10","author":"D Chakroborty","year":"2004","unstructured":"Chakroborty D, Sarkar C, Mitra RB, Banerjee S, Dasgupta PS, Basu S. Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis. Clin Cancer Res. 2004;10:4349\u201356.","journal-title":"Clin Cancer Res"},{"key":"2998_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00403-016-1707-y","volume":"309","author":"A Ortiz-Prieto","year":"2017","unstructured":"Ortiz-Prieto A, Bernabeu-Wittel J, Zulueta-Dorado T, Lorente-Lavirgen AI, Munoz M. Immunolocalization of substance P and NK-1 receptor in vascular anomalies. Arch Dermatol Res. 2017;309:97\u2013102.","journal-title":"Arch Dermatol Res"},{"key":"2998_CR38","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.2174\/0109298673261625230924114406","volume":"31","author":"D Martin-Garcia","year":"2024","unstructured":"Martin-Garcia D, Tellez T, Redondo M, Garcia-Aranda M. The use of SP\/Neurokinin-1 as a therapeutic target in colon and rectal cancer. Curr Med Chem. 2024;31:6487\u2013509.","journal-title":"Curr Med Chem"},{"key":"2998_CR39","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1158\/0008-5472.CAN-23-1012","volume":"83","author":"RH Tu","year":"2023","unstructured":"Tu RH, Wu SZ, Huang ZN, Zhong Q, Ye YH, Zheng CH, Xie JW, Wang JB, Lin JX, Chen QY, et al. Neurotransmitter receptor HTR2B regulates lipid metabolism to inhibit ferroptosis in gastric cancer. Cancer Res. 2023;83:3868\u201385.","journal-title":"Cancer Res"},{"key":"2998_CR40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/j.gastro.2017.03.008","volume":"153","author":"SH Jiang","year":"2017","unstructured":"Jiang SH, Li J, Dong FY, Yang JY, Liu DJ, Yang XM, Wang YH, Yang MW, Fu XL, Zhang XX, et al. Increased serotonin signaling contributes to the warburg effect in pancreatic tumor cells under metabolic stress and promotes growth of pancreatic tumors in mice. Gastroenterology. 2017;153:277\u2013e291219.","journal-title":"Gastroenterology"},{"key":"2998_CR41","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.7150\/thno.70762","volume":"12","author":"L Mao","year":"2022","unstructured":"Mao L, Xin F, Ren J, Xu S, Huang H, Zha X, Wen X, Gu G, Yang G, Cheng Y, et al. 5-HT2B-mediated serotonin activation in enterocytes suppresses colitis-associated cancer initiation and promotes cancer progression. Theranostics. 2022;12:3928\u201345.","journal-title":"Theranostics"},{"key":"2998_CR42","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1016\/j.neuron.2022.04.024","volume":"110","author":"P Zhu","year":"2022","unstructured":"Zhu P, Lu T, Chen Z, Liu B, Fan D, Li C, Wu J, He L, Zhu X, Du Y, et al. 5-hydroxytryptamine produced by enteric serotonergic neurons initiates colorectal cancer stem cell self-renewal and tumorigenesis. Neuron. 2022;110:2268\u2013e22822264.","journal-title":"Neuron"},{"key":"2998_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tips.2007.12.006","volume":"29","author":"RD Egleton","year":"2008","unstructured":"Egleton RD, Brown KC, Dasgupta P. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci. 2008;29:151\u20138.","journal-title":"Trends Pharmacol Sci"},{"key":"2998_CR44","doi-asserted-by":"publisher","first-page":"153473542090989","DOI":"10.1177\/1534735420909895","volume":"19","author":"LT Lin","year":"2020","unstructured":"Lin LT, Choong CY, Tai CJ. Solanine attenuates hepatocarcinoma migration and invasion induced by acetylcholine. Integr Cancer Ther. 2020;19:1534735420909895.","journal-title":"Integr Cancer Ther"},{"key":"2998_CR45","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/carcin\/bgad061","volume":"44","author":"G Kang","year":"2023","unstructured":"Kang G, Jiao Y, Pan P, Fan H, Li Q, Li X, Li J, Wang Y, Jia Y, Wang J, et al. alpha5-nAChR\/STAT3\/CD47 axis contributed to nicotine-related lung adenocarcinoma progression and immune escape. Carcinogenesis. 2023;44:773\u201384.","journal-title":"Carcinogenesis"},{"key":"2998_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2016.11.005","volume":"31","author":"Y Hayakawa","year":"2017","unstructured":"Hayakawa Y, Sakitani K, Konishi M, Asfaha S, Niikura R, Tomita H, Renz BW, Tailor Y, Macchini M, Middelhoff M, et al. Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling. Cancer Cell. 2017;31:21\u201334.","journal-title":"Cancer Cell"},{"key":"2998_CR47","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41419-023-05836-7","volume":"14","author":"YC Wen","year":"2023","unstructured":"Wen YC, Tram VTN, Chen WH, Li CH, Yeh HL, Thuy Dung PV, Jiang KC, Li HR, Huang J, Hsiao M, et al. CHRM4\/AKT\/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer. Cell Death Dis. 2023;14:304.","journal-title":"Cell Death Dis"},{"key":"2998_CR48","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1136\/gutjnl-2018-317479","volume":"68","author":"SH Jiang","year":"2019","unstructured":"Jiang SH, Zhu LL, Zhang M, Li RK, Yang Q, Yan JY, Zhang C, Yang JY, Dong FY, Dai M, et al. GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca2+ signalling in a GABA-independent manner. Gut. 2019;68:1994\u20132006.","journal-title":"Gut"},{"key":"2998_CR49","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","volume":"24","author":"D Huang","year":"2022","unstructured":"Huang D, Wang Y, Thompson JW, Yin T, Alexander PB, Qin D, Mudgal P, Wu H, Liang Y, Tan L, et al. Cancer-cell-derived GABA promotes beta-catenin-mediated tumour growth and immunosuppression. Nat Cell Biol. 2022;24:230\u201341.","journal-title":"Nat Cell Biol"},{"key":"2998_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1615\/CritRevImmunol.2019031188","volume":"39","author":"W Wang","year":"2019","unstructured":"Wang W, Cao X. Beta-adrenergic signaling in tumor immunology and immunotherapy. Crit Rev Immunol. 2019;39:93\u2013103.","journal-title":"Crit Rev Immunol"},{"key":"2998_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00262-018-2243-8","volume":"68","author":"G Qiao","year":"2019","unstructured":"Qiao G, Bucsek MJ, Winder NM, Chen M, Giridharan T, Olejniczak SH, Hylander BL, Repasky EA. beta-Adrenergic signaling blocks murine CD8+ T cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress. Cancer Immunol Immunother. 2019;68:11\u201322.","journal-title":"Cancer Immunol Immunother"},{"key":"2998_CR52","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1158\/2326-6066.CIR-18-0833","volume":"7","author":"C Daher","year":"2019","unstructured":"Daher C, Vimeux L, Stoeva R, Peranzoni E, Bismuth G, Wieduwild E, Lucas B, Donnadieu E, Bercovici N, Trautmann A, Feuillet V. Blockade of beta-adrenergic receptors improves CD8+ T cell. Priming and cancer vaccine efficacy. Cancer Immunol Res. 2019;7:1849\u201363.","journal-title":"Cancer Immunol Res"},{"key":"2998_CR53","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.drup.2014.09.001","volume":"17","author":"MA Peters","year":"2014","unstructured":"Peters MA, Walenkamp AM, Kema IP, Meijer C, de Vries EG, Oosting SF. Dopamine and serotonin regulate tumor behavior by affecting angiogenesis. Drug Resist Updat. 2014;17:96\u2013104.","journal-title":"Drug Resist Updat"},{"key":"2998_CR54","first-page":"933","volume":"2","author":"N Ben-Jonathan","year":"2019","unstructured":"Ben-Jonathan N, Borcherding DC, Fox S, Hugo ER. Activation of the cGMP\/protein kinase G system in breast cancer by the dopamine receptor-1. Cancer Drug Resist. 2019;2:933\u201347.","journal-title":"Cancer Drug Resist"},{"key":"2998_CR55","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.3390\/cancers12113232","volume":"12","author":"P Sobczuk","year":"2020","unstructured":"Sobczuk P, Lomiak M, Cudnoch-Jedrzejewska A. Dopamine D1 Receptor in Cancer. Cancers (Basel). 2020;12:3233.","journal-title":"Cancers (Basel)"},{"key":"2998_CR56","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/carcin\/bgac045","volume":"43","author":"CE Grant","year":"2022","unstructured":"Grant CE, Flis AL, Ryan BM. Understanding the role of dopamine in cancer: past, present and future. Carcinogenesis. 2022;43:517\u201327.","journal-title":"Carcinogenesis"},{"key":"2998_CR57","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neuroscience.2024.12.014","volume":"569","author":"G Ahangari","year":"2025","unstructured":"Ahangari G, Norioun H. The dual role of dopamine and serotonin in cancer progression and inflammation: Mechanisms and therapeutic potential. Neuroscience. 2025;569:184\u201394.","journal-title":"Neuroscience"},{"key":"2998_CR58","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.neubiorev.2016.05.021","volume":"68","author":"C Soares-Cunha","year":"2016","unstructured":"Soares-Cunha C, Coimbra B, Sousa N, Rodrigues AJ. Reappraising striatal D1- and D2-neurons in reward and aversion. Neurosci Biobehav Rev. 2016;68:370\u201386.","journal-title":"Neurosci Biobehav Rev"},{"key":"2998_CR59","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nature09159","volume":"466","author":"AV Kravitz","year":"2010","unstructured":"Kravitz AV, Freeze BS, Parker PR, Kay K, Thwin MT, Deisseroth K, Kreitzer AC. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature. 2010;466:622\u20136.","journal-title":"Nature"},{"key":"2998_CR60","first-page":"1294","volume":"10","author":"L Zhang","year":"2020","unstructured":"Zhang L, Pan J, Chen W, Jiang J, Huang J. Chronic stress-induced immune dysregulation in cancer: implications for initiation, progression, metastasis, and treatment. Am J Cancer Res. 2020;10:1294\u2013307.","journal-title":"Am J Cancer Res"},{"key":"2998_CR61","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s13760-016-0730-2","volume":"117","author":"YL Lan","year":"2017","unstructured":"Lan YL, Wang X, Xing JS, Lou JC, Ma XC, Zhang B. The potential roles of dopamine in malignant glioma. Acta Neurol Belg. 2017;117:613\u201321.","journal-title":"Acta Neurol Belg"},{"key":"2998_CR62","doi-asserted-by":"publisher","first-page":"738252","DOI":"10.3389\/fonc.2021.738252","volume":"11","author":"H Hong","year":"2021","unstructured":"Hong H, Ji M, Lai D. Chronic stress effects on tumor: pathway and mechanism. Front Oncol. 2021;11:738252.","journal-title":"Front Oncol"},{"key":"2998_CR63","doi-asserted-by":"publisher","first-page":"1321176","DOI":"10.3389\/fnins.2023.1321176","volume":"17","author":"Y Lei","year":"2023","unstructured":"Lei Y, Liao F, Tian Y, Wang Y, Xia F, Wang J. Investigating the crosstalk between chronic stress and immune cells: implications for enhanced cancer therapy. Front Neurosci. 2023;17:1321176.","journal-title":"Front Neurosci"},{"key":"2998_CR64","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1158\/1078-0432.CCR-10-2441","volume":"17","author":"M Moreno-Smith","year":"2011","unstructured":"Moreno-Smith M, Lu C, Shahzad MM, Pena GN, Allen JK, Stone RL, Mangala LS, Han HD, Kim HS, Farley D, et al. Dopamine blocks stress-mediated ovarian carcinoma growth. Clin Cancer Res. 2011;17:3649\u201359.","journal-title":"Clin Cancer Res"},{"key":"2998_CR65","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bcp.2015.03.013","volume":"95","author":"S Wang","year":"2015","unstructured":"Wang S, Mou Z, Ma Y, Li J, Li J, Ji X, Wu K, Li L, Lu W, Zhou T. Dopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: Involvement of eradicating cancer stem-like cells. Biochem Pharmacol. 2015;95:98\u2013109.","journal-title":"Biochem Pharmacol"},{"key":"2998_CR66","doi-asserted-by":"publisher","first-page":"188618","DOI":"10.1016\/j.bbcan.2021.188618","volume":"1876","author":"D Ye","year":"2021","unstructured":"Ye D, Xu H, Tang Q, Xia H, Zhang C, Bi F. The role of 5-HT metabolism in cancer. Biochim Biophys Acta Rev Cancer. 2021;1876:188618.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2998_CR67","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.7150\/thno.55986","volume":"11","author":"S Karmakar","year":"2021","unstructured":"Karmakar S, Lal G. Role of serotonin receptor signaling in cancer cells and anti-tumor immunity. Theranostics. 2021;11:5296\u2013312.","journal-title":"Theranostics"},{"key":"2998_CR68","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1085\/jgp.201812066","volume":"151","author":"G Rudnick","year":"2019","unstructured":"Rudnick G, Sandtner W. Serotonin transport in the 21st century. J Gen Physiol. 2019;151:1248\u201364.","journal-title":"J Gen Physiol"},{"key":"2998_CR69","doi-asserted-by":"crossref","unstructured":"Jiang SH, Wang YH, Hu LP, Wang X, Li J, Zhang XL, Zhang ZG. The physiology, pathology and potential therapeutic application of serotonylation. J Cell Sci. 2021;134(11):jcs257337.","DOI":"10.1242\/jcs.257337"},{"key":"2998_CR70","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fnmol.2019.00288","volume":"12","author":"M Bader","year":"2019","unstructured":"Bader M. Serotonylation: serotonin signaling and epigenetics. Front Mol Neurosci. 2019;12:288.","journal-title":"Front Mol Neurosci"},{"key":"2998_CR71","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cmet.2025.11.011","volume":"38","author":"J Li","year":"2026","unstructured":"Li J, Lu J, Zheng C, Huang X, Li H, Mai Q, Chen S, Zhou Z, Zhu J, Yu T, et al. Serotonin-licensed macrophages potentiate chemoresistance via inositol metabolic crosstalk in ovarian cancer. Cell Metab. 2026;38:331\u2013e349310.","journal-title":"Cell Metab"},{"key":"2998_CR72","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00221-002-1259-6","volume":"147","author":"K Tokarski","year":"2002","unstructured":"Tokarski K, Zahorodna A, Bobula B, Hess G. Comparison of the effects of 5-HT1A and 5-HT4 receptor activation on field potentials and epileptiform activity in rat hippocampus. Exp Brain Res. 2002;147:505\u201310.","journal-title":"Exp Brain Res"},{"key":"2998_CR73","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuropharm.2016.08.037","volume":"111","author":"J Amigo","year":"2016","unstructured":"Amigo J, Diaz A, Pilar-Cuellar F, Vidal R, Martin A, Compan V, Pazos A, Castro E. The absence of 5-HT(4) receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT(1A) autoreceptor. Neuropharmacology. 2016;111:47\u201358.","journal-title":"Neuropharmacology"},{"key":"2998_CR74","doi-asserted-by":"publisher","first-page":"e2204006","DOI":"10.1002\/advs.202204006","volume":"10","author":"D Liu","year":"2023","unstructured":"Liu D, Liang CH, Huang B, Zhuang X, Cui W, Yang L, Yang Y, Zhang Y, Fu X, Zhang X, et al. Tryptophan metabolism acts as a new anti-ferroptotic pathway to mediate tumor growth. Adv Sci (Weinh). 2023;10:e2204006.","journal-title":"Adv Sci (Weinh)"},{"key":"2998_CR75","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fcvm.2017.00048","volume":"4","author":"N Herr","year":"2017","unstructured":"Herr N, Bode C, Duerschmied D. The effects of serotonin in immune cells. Front Cardiovasc Med. 2017;4:48.","journal-title":"Front Cardiovasc Med"},{"key":"2998_CR76","doi-asserted-by":"publisher","first-page":"217150","DOI":"10.1016\/j.canlet.2024.217150","volume":"600","author":"T Ling","year":"2024","unstructured":"Ling T, Dai Z, Wang H, Kien TT, Cui R, Yu T, Chen J. Serotonylation in tumor-associated fibroblasts contributes to the tumor-promoting roles of serotonin in colorectal cancer. Cancer Lett. 2024;600:217150.","journal-title":"Cancer Lett"},{"key":"2998_CR77","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13046-023-02836-5","volume":"42","author":"J Pan","year":"2023","unstructured":"Pan J, Zhang L, Wang X, Li L, Yang C, Wang Z, Su K, Hu X, Zhang Y, Ren G, et al. Chronic stress induces pulmonary epithelial cells to produce acetylcholine that remodels lung pre-metastatic niche of breast cancer by enhancing NETosis. J Exp Clin Cancer Res. 2023;42:255.","journal-title":"J Exp Clin Cancer Res"},{"key":"2998_CR78","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.pharmthera.2008.10.007","volume":"121","author":"RD Egleton","year":"2009","unstructured":"Egleton RD, Brown KC, Dasgupta P. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases. Pharmacol Ther. 2009;121:205\u201323.","journal-title":"Pharmacol Ther"},{"key":"2998_CR79","doi-asserted-by":"publisher","first-page":"456743","DOI":"10.1155\/2011\/456743","volume":"2011","author":"S Singh","year":"2011","unstructured":"Singh S, Pillai S, Chellappan S. Nicotinic acetylcholine receptor signaling in tumor growth and metastasis. J Oncol. 2011;2011:456743.","journal-title":"J Oncol"},{"key":"2998_CR80","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.tibs.2024.08.002","volume":"49","author":"B Wu","year":"2024","unstructured":"Wu B, Koehler AN, Westcott PMK. New opportunities to overcome T cell dysfunction: the role of transcription factors and how to target them. Trends Biochem Sci. 2024;49:1014\u201329.","journal-title":"Trends Biochem Sci"},{"key":"2998_CR81","doi-asserted-by":"publisher","first-page":"14498","DOI":"10.1002\/cam4.6102","volume":"12","author":"TJ Li","year":"2023","unstructured":"Li TJ, Jiang J, Tang YL, Liang XH. Insights into the leveraging of GABAergic signaling in cancer therapy. Cancer Med. 2023;12:14498\u2013510.","journal-title":"Cancer Med"},{"key":"2998_CR82","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-021-04082-1","volume":"599","author":"B Zhang","year":"2021","unstructured":"Zhang B, Vogelzang A, Miyajima M, Sugiura Y, Wu Y, Chamoto K, Nakano R, Hatae R, Menzies RJ, Sonomura K, et al. B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity. Nature. 2021;599:471\u20136.","journal-title":"Nature"},{"key":"2998_CR83","doi-asserted-by":"publisher","first-page":"9704","DOI":"10.1158\/0008-5472.CAN-07-2099","volume":"67","author":"A Takehara","year":"2007","unstructured":"Takehara A, Hosokawa M, Eguchi H, Ohigashi H, Ishikawa O, Nakamura Y, Nakagawa H. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit. Cancer Res. 2007;67:9704\u201312.","journal-title":"Cancer Res"},{"key":"2998_CR84","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1440-1746.2008.05687.x","volume":"24","author":"K Maemura","year":"2009","unstructured":"Maemura K, Shiraishi N, Sakagami K, Kawakami K, Inoue T, Murano M, Watanabe M, Otsuki Y. Proliferative effects of gamma-aminobutyric acid on the gastric cancer cell line are associated with extracellular signal-regulated kinase 1\/2 activation. J Gastroenterol Hepatol. 2009;24:688\u201396.","journal-title":"J Gastroenterol Hepatol"},{"key":"2998_CR85","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1245\/s10434-022-12573-2","volume":"30","author":"K Sawaki","year":"2023","unstructured":"Sawaki K, Kanda M, Baba H, Inokawa Y, Hattori N, Hayashi M, Tanaka C, Kodera Y. Gamma-aminobutyric acid type a receptor subunit delta as a potential therapeutic target in gastric cancer. Ann Surg Oncol. 2023;30:628\u201336.","journal-title":"Ann Surg Oncol"},{"key":"2998_CR86","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrn920","volume":"3","author":"Y Ben-Ari","year":"2002","unstructured":"Ben-Ari Y. Excitatory actions of gaba during development: the nature of the nurture. Nat Rev Neurosci. 2002;3:728\u201339.","journal-title":"Nat Rev Neurosci"},{"key":"2998_CR87","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/brainsci12040419","volume":"12","author":"D Bassetti","year":"2022","unstructured":"Bassetti D. Keeping the Balance: GABA(B) Receptors in the developing brain and beyond. Brain Sci. 2022;12:419.","journal-title":"Brain Sci"},{"key":"2998_CR88","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/jdn.10387","volume":"84","author":"X Ji","year":"2024","unstructured":"Ji X, Liu S, Li S, Li X, Luo A, Zhang X, Zhao Y. GABA in early brain development: a dual role review. Int J Dev Neurosci. 2024;84:843\u201356.","journal-title":"Int J Dev Neurosci"},{"key":"2998_CR89","doi-asserted-by":"publisher","first-page":"27487","DOI":"10.1021\/acsnano.4c08055","volume":"18","author":"M Lv","year":"2024","unstructured":"Lv M, Liu B, Duan Y, Lin J, Dai L, Li Y, Yu J, Liao J, Zhang J, Duan Y. Engineered biomimetic nanovesicles synergistically remodel folate-nucleotide and gamma-aminobutyric acid metabolism to overcome sunitinib-resistant renal cell carcinoma. ACS Nano. 2024;18:27487\u2013502.","journal-title":"ACS Nano"},{"key":"2998_CR90","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1369\/0022155412438105","volume":"60","author":"X Jiang","year":"2012","unstructured":"Jiang X, Su L, Zhang Q, He C, Zhang Z, Yi P, Liu J. GABAB receptor complex as a potential target for tumor therapy. J Histochem Cytochem. 2012;60:269\u201379.","journal-title":"J Histochem Cytochem"},{"key":"2998_CR91","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.ijrobp.2020.10.025","volume":"109","author":"DA Pomeranz Krummel","year":"2021","unstructured":"Pomeranz Krummel DA, Nasti TH, Kaluzova M, Kallay L, Bhattacharya D, Melms JC, Izar B, Xu M, Burnham A, Ahmed T, et al. Melanoma cell intrinsic GABA(A) receptor enhancement potentiates radiation and immune checkpoint inhibitor response by promoting direct and T Cell-mediated antitumor activity. Int J Radiat Oncol Biol Phys. 2021;109:1040\u201353.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2998_CR92","doi-asserted-by":"publisher","first-page":"9417","DOI":"10.1038\/s41598-017-09639-7","volume":"7","author":"JE Lim","year":"2017","unstructured":"Lim JE, Chung E, Son Y. A neuropeptide, Substance-P, directly induces tissue-repairing M2 like macrophages by activating the PI3K\/Akt\/mTOR pathway even in the presence of IFNgamma. Sci Rep. 2017;7:9417.","journal-title":"Sci Rep"},{"key":"2998_CR93","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252\u201364.","journal-title":"Nat Rev Cancer"},{"key":"2998_CR94","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.3389\/fimmu.2018.02821","volume":"9","author":"XM Zhou","year":"2018","unstructured":"Zhou XM, Li WQ, Wu YH, Han L, Cao XG, Yang XM, Wang HF, Zhao WS, Zhai WJ, Qi YM, Gao YF. Intrinsic expression of immune checkpoint molecule TIGIT could help tumor growth in vivo by suppressing the function of NK and CD8+ T Cells. Front Immunol. 2018;9:2821.","journal-title":"Front Immunol"},{"key":"2998_CR95","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41413-019-0059-6","volume":"7","author":"J Luo","year":"2019","unstructured":"Luo J, Sun P, Siwko S, Liu M, Xiao J. The role of GPCRs in bone diseases and dysfunctions. Bone Res. 2019;7:19.","journal-title":"Bone Res"},{"key":"2998_CR96","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.npep.2018.11.008","volume":"73","author":"M Czarnecka","year":"2019","unstructured":"Czarnecka M, Lu C, Pons J, Maheswaran I, Ciborowski P, Zhang L, Cheema A, Kitlinska J. Neuropeptide Y receptor interactions regulate its mitogenic activity. Neuropeptides. 2019;73:11\u201324.","journal-title":"Neuropeptides"},{"key":"2998_CR97","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s12015-019-09904-4","volume":"15","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zhang Y. ETV5 is Essential for neuronal differentiation of human neural progenitor cells by repressing NEUROG2 expression. Stem Cell Rev Rep. 2019;15:703\u201316.","journal-title":"Stem Cell Rev Rep"},{"key":"2998_CR98","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/gutjnl-2024-333944","volume":"74","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Huang W, Hu D, Jiang J, Zhang J, Wu Z, Wen J, Luo X, Wang Y, Sun M, et al. E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression. Gut. 2025;74:1137\u201349.","journal-title":"Gut"},{"key":"2998_CR99","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.7150\/ijms.71892","volume":"19","author":"MC Sun","year":"2022","unstructured":"Sun MC, Fang K, Li ZX, Chu Y, Xu AP, Zhao ZY, Leng ZY, Zhang YW, Zhang ZH, Zhang L, et al. ETV5 overexpression promotes progression of esophageal squamous cell carcinoma by upregulating SKA1 and TRPV2. Int J Med Sci. 2022;19:1072\u201381.","journal-title":"Int J Med Sci"},{"key":"2998_CR100","doi-asserted-by":"publisher","first-page":"417","DOI":"10.5483\/BMBRep.2017.50.8.099","volume":"50","author":"MH Park","year":"2017","unstructured":"Park MH, Jung IK, Min WK, Choi JH, Kim GM, Jin HK, Bae JS. Neuropeptide Y improves cisplatin-induced bone marrow dysfunction without blocking chemotherapeutic efficacy in a cancer mouse model. BMB Rep. 2017;50:417\u201322.","journal-title":"BMB Rep"},{"key":"2998_CR101","first-page":"211","volume":"22","author":"S Liu","year":"2023","unstructured":"Liu S, Wu J, Feng Y, Guo X, Li T, Meng M, Chen J, Chen D, Tian H. CD47KO\/CRT dual-bioengineered cell membrane-coated nanovaccine combined with anti-PD-L1 antibody for boosting tumor immunotherapy. Bioact Mater. 2023;22:211\u201324.","journal-title":"Bioact Mater"},{"key":"2998_CR102","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1158\/0008-5472.CAN-17-0468","volume":"77","author":"H Jiang","year":"2017","unstructured":"Jiang H, Rivera-Molina Y, Gomez-Manzano C, Clise-Dwyer K, Bover L, Vence LM, Yuan Y, Lang FF, Toniatti C, Hossain MB, Fueyo J. Oncolytic adenovirus and tumor-targeting immune modulatory therapy improve autologous cancer vaccination. Cancer Res. 2017;77:3894\u2013907.","journal-title":"Cancer Res"},{"key":"2998_CR103","doi-asserted-by":"publisher","first-page":"112603","DOI":"10.1016\/j.msec.2021.112603","volume":"133","author":"C Jin","year":"2022","unstructured":"Jin C, Zhang Y, Zhang G, Wang B, Hua P. Combination of GNRs-PEI\/cGAMP-laden macrophages-based photothermal induced in situ tumor vaccines and immune checkpoint blockade for synergistic anti-tumor immunotherapy. Biomater Adv. 2022;133:112603.","journal-title":"Biomater Adv"},{"key":"2998_CR104","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41568-025-00831-w","volume":"25","author":"M Amit","year":"2025","unstructured":"Amit M, Eichwald T, Roger A, Anderson J, Chang A, Vermeer PD, Dixon KO, Scheff NN, Talbot S. Neuro-immune cross-talk in cancer. Nat Rev Cancer. 2025;25:573\u201389.","journal-title":"Nat Rev Cancer"},{"key":"2998_CR105","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1021\/cn500329r","volume":"6","author":"NA Muma","year":"2015","unstructured":"Muma NA, Mi Z. Serotonylation and transamidation of other monoamines. ACS Chem Neurosci. 2015;6:961\u20139.","journal-title":"ACS Chem Neurosci"},{"key":"2998_CR106","doi-asserted-by":"publisher","first-page":"5947","DOI":"10.1038\/s41467-025-61197-z","volume":"16","author":"S Lin","year":"2025","unstructured":"Lin S, Tan S, Peng Y, Tulamaiti A, Du W, Ding K, Chen C, Wu J, Li H, Xu W, et al. Histone serotonylation promotes pancreatic cancer development via lipid metabolism remodeling. Nat Commun. 2025;16:5947.","journal-title":"Nat Commun"},{"key":"2998_CR107","doi-asserted-by":"publisher","first-page":"BSR20240493","DOI":"10.1042\/BSR20240493","volume":"44","author":"H Li","year":"2024","unstructured":"Li H, Wu J, Zhang N, Zheng Q. Transglutaminase 2-mediated histone monoaminylation and its role in cancer. Biosci Rep. 2024;44:BSR20240493.","journal-title":"Biosci Rep"},{"key":"2998_CR108","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41586-024-07751-z","volume":"632","author":"HC Chen","year":"2024","unstructured":"Chen HC, He P, McDonald M, Williamson MR, Varadharajan S, Lozzi B, Woo J, Choi DJ, Sardar D, Huang-Hobbs E, et al. Histone serotonylation regulates ependymoma tumorigenesis. Nature. 2024;632:903\u201310.","journal-title":"Nature"},{"key":"2998_CR109","doi-asserted-by":"publisher","first-page":"1325050","DOI":"10.3389\/fphar.2023.1325050","volume":"14","author":"R Massalee","year":"2023","unstructured":"Massalee R, Cao X. Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies. Front Pharmacol. 2023;14:1325050.","journal-title":"Front Pharmacol"},{"key":"2998_CR110","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.psyneuen.2018.09.012","volume":"99","author":"AK Walker","year":"2019","unstructured":"Walker AK, Martelli D, Ziegler AI, Lambert GW, Phillips SE, Hill SJ, McAllen RM, Sloan EK. Circulating epinephrine is not required for chronic stress to enhance metastasis. Psychoneuroendocrinology. 2019;99:191\u20135.","journal-title":"Psychoneuroendocrinology"},{"key":"2998_CR111","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.psyneuen.2014.10.004","volume":"51","author":"DM Lamkin","year":"2015","unstructured":"Lamkin DM, Sung HY, Yang GS, David JM, Ma JC, Cole SW, Sloan EK. alpha2-Adrenergic blockade mimics the enhancing effect of chronic stress on breast cancer progression. Psychoneuroendocrinology. 2015;51:262\u201370.","journal-title":"Psychoneuroendocrinology"},{"key":"2998_CR112","doi-asserted-by":"publisher","first-page":"110825","DOI":"10.1016\/j.intimp.2023.110825","volume":"124","author":"RK Tiwari","year":"2023","unstructured":"Tiwari RK, Rawat SG, Kumar A. The antagonist of beta-adrenergic receptor propranolol inhibits T cell lymphoma growth and enhances antitumor efficacy of cisplatin in vivo: A role of modulated apoptosis, glucose metabolism, pH regulation, and antitumor immune response. Int Immunopharmacol. 2023;124:110825.","journal-title":"Int Immunopharmacol"},{"key":"2998_CR113","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1476-4598-10-146","volume":"10","author":"D Zhang","year":"2011","unstructured":"Zhang D, Ma Q, Wang Z, Zhang M, Guo K, Wang F, Wu E. beta2-adrenoceptor blockage induces G1\/S phase arrest and apoptosis in pancreatic cancer cells via Ras\/Akt\/NFkappaB pathway. Mol Cancer. 2011;10:146.","journal-title":"Mol Cancer"},{"key":"2998_CR114","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4161\/cbt.10.1.11944","volume":"10","author":"D Zhang","year":"2010","unstructured":"Zhang D, Ma QY, Hu HT, Zhang M. beta2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFkappaB and AP-1. Cancer Biol Ther. 2010;10:19\u201329.","journal-title":"Cancer Biol Ther"},{"key":"2998_CR115","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13046-023-02728-8","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang X, Wang K, Qi J, Zhang Y, Wang X, Zhang L, Zhou Y, Gu L, Yu R, Zhou X. Chronic stress accelerates glioblastoma progression via DRD2\/ERK\/beta-catenin axis and Dopamine\/ERK\/TH positive feedback loop. J Exp Clin Cancer Res. 2023;42:161.","journal-title":"J Exp Clin Cancer Res"},{"key":"2998_CR116","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/14728222.2019.1606904","volume":"23","author":"R Bakadlag","year":"2019","unstructured":"Bakadlag R, Jandaghi P, Hoheisel JD, Riazalhosseini Y. The potential of dopamine receptor D2 (DRD2) as a therapeutic target for tackling pancreatic cancer. Expert Opin Ther Targets. 2019;23:365\u20137.","journal-title":"Expert Opin Ther Targets"},{"key":"2998_CR117","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1158\/0008-5472.CAN-21-3077","volume":"81","author":"DG Bernabe","year":"2021","unstructured":"Bernabe DG. Catecholamines Mediate Psychologic Stress-Induced Cancer Progression. Cancer Res. 2021;81:5144\u20136.","journal-title":"Cancer Res"},{"key":"2998_CR118","doi-asserted-by":"publisher","first-page":"eabc8188","DOI":"10.1126\/scitranslmed.abc8188","volume":"13","author":"MA Schneider","year":"2021","unstructured":"Schneider MA, Heeb L, Beffinger MM, Pantelyushin S, Linecker M, Roth L, Lehmann K, Ungethum U, Kobold S, Graf R, et al. Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models. Sci Transl Med. 2021;13:eabc8188.","journal-title":"Sci Transl Med"},{"key":"2998_CR119","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1038\/s41598-021-84225-6","volume":"11","author":"J Nishimura","year":"2021","unstructured":"Nishimura J, Hasegawa A, Kudo T, Otsuka T, Yasui M, Matsuda C, Haraguchi N, Ushigome H, Nakai N, Abe T, et al. A phase II study of the safety of olanzapine for oxaliplatin based chemotherapy in coloraectal patients. Sci Rep. 2021;11:4547.","journal-title":"Sci Rep"},{"key":"2998_CR120","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1186\/s12885-023-11410-3","volume":"23","author":"N Kuol","year":"2023","unstructured":"Kuol N, Godlewski J, Kmiec Z, Vogrin S, Fraser S, Apostolopoulos V, Nurgali K. Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines. BMC Cancer. 2023;23:971.","journal-title":"BMC Cancer"},{"key":"2998_CR121","doi-asserted-by":"publisher","first-page":"114410","DOI":"10.1016\/j.biopha.2023.114410","volume":"161","author":"Y Yang","year":"2023","unstructured":"Yang Y, Ren L, Li W, Zhang Y, Zhang S, Ge B, Yang H, Du G, Tang B, Wang H, Wang J. GABAergic signaling as a potential therapeutic target in cancers. Biomed Pharmacother. 2023;161:114410.","journal-title":"Biomed Pharmacother"},{"key":"2998_CR122","doi-asserted-by":"publisher","first-page":"123067","DOI":"10.1016\/j.lfs.2024.123067","volume":"357","author":"S Sun","year":"2024","unstructured":"Sun S, Chen X, Ding N, Zhang M, Li X, Chen L, Sun K, Liu Y. Gamma-aminobutyric acid-mediated neuro-immune interactions in glioblastoma: Implications for prognosis and immunotherapy response. Life Sci. 2024;357:123067.","journal-title":"Life Sci"},{"key":"2998_CR123","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/path.5147","volume":"246","author":"E Saponara","year":"2018","unstructured":"Saponara E, Visentin M, Baschieri F, Seleznik G, Martinelli P, Esposito I, Buschmann J, Chen R, Parrotta R, Borgeaud N, et al. Serotonin uptake is required for Rac1 activation in Kras-induced acinar-to-ductal metaplasia in the pancreas. J Pathol. 2018;246:352\u201365.","journal-title":"J Pathol"},{"key":"2998_CR124","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jhep.2024.12.038","volume":"83","author":"R Dong","year":"2025","unstructured":"Dong R, Wang T, Dong W, Zhang H, Li Y, Tao R, Liu Q, Liang H, Chen X, Zhang B, Zhang X. TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway. J Hepatol. 2025;83:105\u201318.","journal-title":"J Hepatol"},{"key":"2998_CR125","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.3390\/cancers16132387","volume":"16","author":"M Moriguchi","year":"2024","unstructured":"Moriguchi M, Kataoka S, Itoh Y. Evolution of systemic treatment for hepatocellular carcinoma: changing treatment strategies and concepts. Cancers (Basel). 2024;16:2387.","journal-title":"Cancers (Basel)"},{"key":"2998_CR126","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1038\/onc.2015.369","volume":"35","author":"DC Borcherding","year":"2016","unstructured":"Borcherding DC, Tong W, Hugo ER, Barnard DF, Fox S, LaSance K, Shaughnessy E, Ben-Jonathan N. Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer. Oncogene. 2016;35:3103\u201313.","journal-title":"Oncogene"},{"key":"2998_CR127","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1021\/acsami.5b00270","volume":"7","author":"J Li","year":"2015","unstructured":"Li J, Shen Z, Ma X, Ren W, Xiang L, Gong A, Xia T, Guo J, Wu A. Neuropeptide Y Y1 receptors mediate [corrected] targeted delivery of anticancer drug with encapsulated nanoparticles to breast cancer cells with high selectivity and its potential for breast cancer therapy. ACS Appl Mater Interfaces. 2015;7:5574\u201382.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2998_CR128","doi-asserted-by":"publisher","first-page":"14982","DOI":"10.1021\/acsnano.2c06026","volume":"16","author":"X Li","year":"2022","unstructured":"Li X, Zhou Q, Japir A, Dutta D, Lu N, Ge Z. Protein-delivering nanocomplexes with fenton reaction-triggered cargo release to boost cancer immunotherapy. ACS Nano. 2022;16:14982\u201399.","journal-title":"ACS Nano"},{"key":"2998_CR129","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00262-020-02816-0","volume":"70","author":"Q Liu","year":"2021","unstructured":"Liu Q, Zhang R, Zhang X, Liu J, Wu H, Li Y, Cui M, Li T, Song H, Gao J, et al. Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. Cancer Immunol Immunother. 2021;70:2165\u201377.","journal-title":"Cancer Immunol Immunother"},{"key":"2998_CR130","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1158\/0008-5472.CAN-21-4084","volume":"82","author":"Y Chen","year":"2022","unstructured":"Chen Y, Yan SM, Pu Z, Feng J, Tan L, Li Y, Hu H, Huang W, Lin Y, Peng Z, et al. Dopamine signaling promotes tissue-resident memory differentiation of CD8+ T cells and antitumor immunity. Cancer Res. 2022;82:3130\u201342.","journal-title":"Cancer Res"},{"key":"2998_CR131","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.3390\/biomedicines10092081","volume":"10","author":"A Kuzevanova","year":"2022","unstructured":"Kuzevanova A, Apanovich N, Mansorunov D, Korotaeva A, Karpukhin A. The features of checkpoint receptor-ligand interaction in cancer and the therapeutic effectiveness of their inhibition. Biomedicines. 2022;10:2081.","journal-title":"Biomedicines"},{"key":"2998_CR132","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","volume":"622","author":"AM Globig","year":"2023","unstructured":"Globig AM, Zhao S, Roginsky J, Maltez VI, Guiza J, Avina-Ochoa N, Heeg M, Araujo Hoffmann F, Chaudhary O, Wang J, et al. The beta(1)-adrenergic receptor links sympathetic nerves to T cell exhaustion. Nature. 2023;622:383\u201392.","journal-title":"Nature"},{"key":"2998_CR133","doi-asserted-by":"publisher","first-page":"12837","DOI":"10.3390\/ijms241612837","volume":"24","author":"MA Farooq","year":"2023","unstructured":"Farooq MA, Ajmal I, Hui X, Chen Y, Ren Y, Jiang W. beta2-Adrenergic receptor mediated inhibition of T Cell function and its implications for CAR-T cell therapy. Int J Mol Sci. 2023;24:12837.","journal-title":"Int J Mol Sci"},{"key":"2998_CR134","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1016\/j.ymthe.2024.08.028","volume":"32","author":"I Ajmal","year":"2024","unstructured":"Ajmal I, Farooq MA, Duan Y, Yao J, Gao Y, Hui X, Ge Y, Chen Y, Ren Y, Du B, Jiang W. Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer. Mol Ther. 2024;32:3539\u201357.","journal-title":"Mol Ther"},{"key":"2998_CR135","doi-asserted-by":"publisher","first-page":"102159","DOI":"10.1016\/j.npep.2021.102159","volume":"89","author":"M Levite","year":"2021","unstructured":"Levite M, Safadi R, Milgrom Y, Massarwa M, Galun E. Neurotransmitters and Neuropeptides decrease PD-1 in T cells of healthy subjects and patients with hepatocellular carcinoma (HCC), and increase their proliferation and eradication of HCC cells. Neuropeptides. 2021;89:102159.","journal-title":"Neuropeptides"},{"key":"2998_CR136","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00702-014-1242-y","volume":"121","author":"S Saussez","year":"2014","unstructured":"Saussez S, Laumbacher B, Chantrain G, Rodriguez A, Gu S, Wank R, Levite M. Towards neuroimmunotherapy for cancer: the neurotransmitters glutamate, dopamine and GnRH-II augment substantially the ability of T cells of few head and neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chains. J Neural Transm (Vienna). 2014;121:1007\u201327.","journal-title":"J Neural Transm (Vienna)"},{"key":"2998_CR137","doi-asserted-by":"publisher","first-page":"eabh2383","DOI":"10.1126\/sciimmunol.abh2383","volume":"6","author":"X Wang","year":"2021","unstructured":"Wang X, Li B, Kim YJ, Wang YC, Li Z, Yu J, Zeng S, Ma X, Choi IY, Di Biase S, et al. Targeting monoamine oxidase A for T cell-based cancer immunotherapy. Sci Immunol. 2021;6:eabh2383.","journal-title":"Sci Immunol"},{"key":"2998_CR138","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.drudis.2014.03.022","volume":"19","author":"A Fernandez","year":"2014","unstructured":"Fernandez A. Synergizing immunotherapy with molecular-targeted anticancer treatment. Drug Discov Today. 2014;19:1427\u201332.","journal-title":"Drug Discov Today"},{"key":"2998_CR139","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1158\/2326-6066.CIR-20-0061","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Chokkalingam N, Tello-Ruiz E, Wise MC, Bah MA, Walker S, Tursi NJ, Fisher PD, Schultheis K, Broderick KE, et al. A DNA-launched nanoparticle vaccine elicits CD8+ T cell immunity to promote in vivo tumor control. Cancer Immunol Res. 2020;8:1354\u201364.","journal-title":"Cancer Immunol Res"},{"key":"2998_CR140","doi-asserted-by":"publisher","first-page":"e2300418","DOI":"10.1002\/advs.202300418","volume":"10","author":"C Xie","year":"2023","unstructured":"Xie C, You X, Zhang H, Li J, Wang L, Liu Y, Wang Z, Yao R, Tong T, Li M, et al. A nanovaccine based on adjuvant peptide FK-13 and l-Phenylalanine Poly(ester amide) Enhances CD8+ T Cell-mediated antitumor immunity. Adv Sci (Weinh). 2023;10:e2300418.","journal-title":"Adv Sci (Weinh)"},{"key":"2998_CR141","doi-asserted-by":"publisher","first-page":"1682322","DOI":"10.3389\/fimmu.2025.1682322","volume":"16","author":"L Xu","year":"2025","unstructured":"Xu L, Chen S, Fu Y, Zhou T, Yu J, Li J, Chen W. Neuro-immune-tumor axis in gliomas: a review of mechanisms, models, and translational opportunities. Front Immunol. 2025;16:1682322.","journal-title":"Front Immunol"},{"key":"2998_CR142","doi-asserted-by":"publisher","first-page":"104958","DOI":"10.1016\/j.critrevonc.2025.104958","volume":"216","author":"N Xu","year":"2025","unstructured":"Xu N, Bian S, Lyu P, He X, Zheng W. Dynamic interplay of neuroendocrine signaling and immuno-surveillance in tumor niche remodeling. Crit Rev Oncol Hematol. 2025;216:104958.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2998_CR143","doi-asserted-by":"publisher","first-page":"218070","DOI":"10.1016\/j.canlet.2025.218070","volume":"634","author":"F Vanden Abeele","year":"2025","unstructured":"Vanden Abeele F, Salzet M. The neuro-immune oncology axis. Cancer Lett. 2025;634:218070.","journal-title":"Cancer Lett"},{"key":"2998_CR144","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00262-023-03622-0","volume":"73","author":"Y Ma","year":"2024","unstructured":"Ma Y, Chen H, Li H, Zhao Z, An Q, Shi C. Targeting monoamine oxidase A: a strategy for inhibiting tumor growth with both immune checkpoint inhibitors and immune modulators. Cancer Immunol Immunother. 2024;73:48.","journal-title":"Cancer Immunol Immunother"},{"key":"2998_CR145","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/cells15050409","volume":"15","author":"H Zhao","year":"2026","unstructured":"Zhao H, Jiang Q, Wang Q, Wang Z, Huang Y, Lei T. Beyond epilepsy control: repurposing antiepileptic drugs in central nervous system tumor therapy. Cells. 2026;15:409.","journal-title":"Cells"},{"key":"2998_CR146","doi-asserted-by":"publisher","first-page":"103011","DOI":"10.1016\/j.ctrv.2025.103011","volume":"140","author":"DL Nielsen","year":"2025","unstructured":"Nielsen DL, Juhl CB, Chen IM, Wang Y, Nielsen OH, Santomasso BD. Immune checkpoint inhibitor-related neurotoxicity: Incidence and management. A systematic review and meta-analysis. Cancer Treat Rev. 2025;140:103011.","journal-title":"Cancer Treat Rev"},{"key":"2998_CR147","doi-asserted-by":"publisher","first-page":"578752","DOI":"10.1016\/j.jneuroim.2025.578752","volume":"409","author":"GD Vieira","year":"2025","unstructured":"Vieira GD, Boldrini VO, Schlindwen L, de Souza Filho ECP, Schulz ME, de Souza FF, Trevisani JP, Campezato PH, Haag A, Goncalves MVM. Cranial neuropathies related to immune checkpoint inhibitors. J Neuroimmunol. 2025;409:578752.","journal-title":"J Neuroimmunol"},{"key":"2998_CR148","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1021\/acsnano.1c08120","volume":"16","author":"H Wang","year":"2022","unstructured":"Wang H, Chao Y, Zhao H, Zhou X, Zhang F, Zhang Z, Li Z, Pan J, Wang J, Chen Q, Liu Z. Smart nanomedicine to enable crossing blood-brain barrier delivery of checkpoint blockade antibody for immunotherapy of glioma. ACS Nano. 2022;16:664\u201374.","journal-title":"ACS Nano"},{"key":"2998_CR149","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000501646","volume":"88","author":"M Stoffel","year":"2019","unstructured":"Stoffel M, Aguilar-Raab C, Rahn S, Steinhilber B, Witt SH, Alexander N, Ditzen B. Effects of mindfulness-based stress prevention on serotonin transporter gene methylation. Psychother Psychosom. 2019;88:317\u20139.","journal-title":"Psychother Psychosom"},{"key":"2998_CR150","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.3390\/biomedicines12112613","volume":"12","author":"A Calderone","year":"2024","unstructured":"Calderone A, Latella D, Impellizzeri F, de Pasquale P, Fama F, Quartarone A, Calabro RS. Neurobiological changes induced by mindfulness and meditation: a systematic review. Biomedicines. 2024;12:2613.","journal-title":"Biomedicines"},{"key":"2998_CR151","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1200\/JCO.21.00279","volume":"39","author":"JE Bower","year":"2021","unstructured":"Bower JE, Partridge AH, Wolff AC, Thorner ED, Irwin MR, Joffe H, Petersen L, Crespi CM, Ganz PA. Targeting depressive symptoms in younger breast cancer survivors: the pathways to wellness randomized controlled trial of mindfulness meditation and survivorship education. J Clin Oncol. 2021;39:3473\u201384.","journal-title":"J Clin Oncol"},{"key":"2998_CR152","doi-asserted-by":"publisher","first-page":"153473542090834","DOI":"10.1177\/1534735420908341","volume":"19","author":"E Arden-Close","year":"2020","unstructured":"Arden-Close E, Mitchell F, Davies G, Bell L, Fogg C, Tarrant R, Gibbs R, Yeoh CC. Mindfulness-based interventions in recurrent ovarian cancer: a mixed-methods feasibility study. Integr Cancer Ther. 2020;19:1534735420908341.","journal-title":"Integr Cancer Ther"},{"key":"2998_CR153","doi-asserted-by":"publisher","first-page":"e47745","DOI":"10.2196\/47745","volume":"13","author":"AS Orasud","year":"2024","unstructured":"Orasud AS, Uchiyama M, Pagano I, Bantum E. Mobile mindfulness meditation for cancer-related anxiety and neuropathy: protocol for a randomized controlled trial. JMIR Res Protoc. 2024;13:e47745.","journal-title":"JMIR Res Protoc"},{"key":"2998_CR154","doi-asserted-by":"publisher","first-page":"106396","DOI":"10.1016\/j.neubiorev.2025.106396","volume":"179","author":"M Yu","year":"2025","unstructured":"Yu M, Jin Y, An J, Zheng P. The effect of mindfulness-based meditation on the immune function of breast cancer patients: a systematic review and three-level meta-analysis. Neurosci Biobehav Rev. 2025;179:106396.","journal-title":"Neurosci Biobehav Rev"},{"key":"2998_CR155","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1158\/2159-8290.CD-25-0974","volume":"16","author":"Y Ji","year":"2026","unstructured":"Ji Y, Ju CW, Chen L, Shen K, Su R, Li A, Liu X, Liu B, Zhang X, Lyu R, et al. Serotonin modulates lineage plasticity in neuroendocrine prostate cancer via epigenetic reprogramming. Cancer Discov. 2026;16:760\u201380.","journal-title":"Cancer Discov"},{"key":"2998_CR156","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fcell.2020.00216","volume":"8","author":"B Gonzalez","year":"2020","unstructured":"Gonzalez B, Gancedo SN, Garazatua SAJ, Roldan E, Vitullo AD, Gonzalez CR. Dopamine receptor D1 contributes to cocaine epigenetic reprogramming of histone modifications in male germ cells. Front Cell Dev Biol. 2020;8:216.","journal-title":"Front Cell Dev Biol"},{"key":"2998_CR157","doi-asserted-by":"publisher","first-page":"e2100096","DOI":"10.1002\/adma.202100096","volume":"34","author":"MJ Mosquera","year":"2022","unstructured":"Mosquera MJ, Kim S, Bareja R, Fang Z, Cai S, Pan H, Asad M, Martin ML, Sigouros M, Rowdo FM, et al. Extracellular matrix in synthetic hydrogel-based prostate cancer organoids regulate therapeutic response to EZH2 and DRD2 inhibitors. Adv Mater. 2022;34:e2100096.","journal-title":"Adv Mater"},{"key":"2998_CR158","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1016\/j.immuni.2025.10.003","volume":"58","author":"R Feng","year":"2025","unstructured":"Feng R, Spieth L, Liu L, Berghoff S, Franz J, Liu Q, Wang Z, Tiwari V, Vitale S, Frerich S, et al. Single-cell spatial transcriptomic profiling defines a pathogenic inflammatory niche in chronic active multiple sclerosis lesions. Immunity. 2025;58:2989\u2013e30052910.","journal-title":"Immunity"},{"key":"2998_CR159","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41380-024-02651-0","volume":"30","author":"KG Johnston","year":"2025","unstructured":"Johnston KG, Berackey BT, Tran KM, Gelber A, Yu Z, MacGregor GR, Mukamel EA, Tan Z, Green KN, Xu X. Single-cell spatial transcriptomics reveals distinct patterns of dysregulation in non-neuronal and neuronal cells induced by the Trem2(R47H) Alzheimer\u2019s risk gene mutation. Mol Psychiatry. 2025;30:461\u201377.","journal-title":"Mol Psychiatry"},{"key":"2998_CR160","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41467-025-56124-1","volume":"16","author":"R Martins-Ferreira","year":"2025","unstructured":"Martins-Ferreira R, Calafell-Segura J, Leal B, Rodriguez-Ubreva J, Martinez-Saez E, Mereu E, Pinho ECP, Laguna A, Ballestar E. The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions. Nat Commun. 2025;16:739.","journal-title":"Nat Commun"},{"key":"2998_CR161","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/j.cmet.2025.10.012","volume":"37","author":"LF Barros","year":"2025","unstructured":"Barros LF, Fernandez-Moncada I, Marsicano G, Ruminot I, Saab AS, Weber B. Scale-spanning crosstalk between metabolism and information processing. Cell Metab. 2025;37:2303\u201310.","journal-title":"Cell Metab"},{"key":"2998_CR162","doi-asserted-by":"publisher","first-page":"480","DOI":"10.14336\/AD.2023.0727","volume":"15","author":"W Deng","year":"2024","unstructured":"Deng W, Yi P, Xiong Y, Ying J, Lin Y, Dong Y, Wei G, Wang X, Hua F. Gut Metabolites acting on the gut-brain axis: regulating the functional state of microglia. Aging Dis. 2024;15:480\u2013502.","journal-title":"Aging Dis"},{"key":"2998_CR163","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12974-025-03454-y","volume":"22","author":"Q Cao","year":"2025","unstructured":"Cao Q, Shen M, Li R, Liu Y, Zeng Z, Zhou J, Niu D, Zhang Q, Wang R, Yao J, Zhang G. Elucidating the specific mechanisms of the gut-brain axis: the short-chain fatty acids-microglia pathway. J Neuroinflammation. 2025;22:133.","journal-title":"J Neuroinflammation"},{"key":"2998_CR164","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.3390\/ijms21217958","volume":"21","author":"B Mravec","year":"2020","unstructured":"Mravec B, Horvathova L, Hunakova L. Neurobiology of cancer: the role of beta-adrenergic receptor signaling in various tumor environments. Int J Mol Sci. 2020;21:7958.","journal-title":"Int J Mol Sci"},{"key":"2998_CR165","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.trecan.2021.10.005","volume":"8","author":"H Wackerhage","year":"2022","unstructured":"Wackerhage H, Christensen JF, Ilmer M, von Luettichau I, Renz BW, Schonfelder M. Cancer catecholamine conundrum. Trends Cancer. 2022;8:110\u201322.","journal-title":"Trends Cancer"},{"key":"2998_CR166","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3389\/fonc.2019.01077","volume":"9","author":"CB Colon-Echevarria","year":"2019","unstructured":"Colon-Echevarria CB, Lamboy-Caraballo R, Aquino-Acevedo AN, Armaiz-Pena GN. Neuroendocrine regulation of tumor-associated immune cells. Front Oncol. 2019;9:1077.","journal-title":"Front Oncol"},{"key":"2998_CR167","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s11912-024-01571-0","volume":"26","author":"K Kaira","year":"2024","unstructured":"Kaira K, Mouri A, Imai H, Yamaguchi O, Kagamu H. Clinical issue of myasthenia gravis related to immune checkpoint inhibitors. Curr Oncol Rep. 2024;26:1113\u20139.","journal-title":"Curr Oncol Rep"},{"key":"2998_CR168","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","volume":"23","author":"G Millan-Zambrano","year":"2022","unstructured":"Millan-Zambrano G, Burton A, Bannister AJ, Schneider R. Histone post-translational modifications - cause and consequence of genome function. Nat Rev Genet. 2022;23:563\u201380.","journal-title":"Nat Rev Genet"},{"key":"2998_CR169","doi-asserted-by":"crossref","first-page":"7966","DOI":"10.3390\/ijms25147966","volume":"25","author":"PM Lai","year":"2024","unstructured":"Lai PM, Gong X, Chan KM. Roles of histone H2B, H3 and H4 variants in cancer development and prognosis. Int J Mol Sci. 2024;25:7966.","journal-title":"Int J Mol Sci"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02998-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02998-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02998-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:02:56Z","timestamp":1787580176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02998-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":169,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2998"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02998-7","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"453"}}